Page 13 - PROSTATE CANCER
P. 13
4. CCR (clinical cell-cycle risk score) - uIR/HR pCa who can forgo ADT?
Absolute benefit of ADT in
uIR and HR with CCR <2.112
as low as 1-2%
Dr. Tward U. of Utah
